Just like buses, after waiting all year for a COVID vaccine to arrive, two have come along at once.
We feel the newer one is particularly worth drawing your attention to. This is because its clinical trial reports that the Moderna COVID vaccine effects on dermal filler patients may include facial swelling.
Moderna coronavirus vaccine
The coronavirus vaccine developed by Pfizer/BioNTech is currently being rolled out across the UK and USA. It is said to have a 94 per cent efficacy rating in people aged 65 years and over.
In America, the Moderna vaccine has also now been authorised for emergency use in adults aged 18 and over by the FDA. Reporting efficacy ratings of 94 per cent at preventing COVID-19 and 100 per cent against severe COVID, it is expected to hit the UK soon. The government has reportedly already secured enough of these shots to immunise approximately 3.5 million citizens.
As with the Pfizer shots, the Moderna vaccine is administered in two separate intramuscular doses, one month apart. One of the key differences between the two is the temperature at which they must be kept. Pfizer requires its vaccines to be kept at sub-zero temperatures of approximately -70 degrees Celsius throughout the delivery chain. More conveniently, the Moderna option can be stored in a normal refrigerator, which may increase its popularity.
Contraindications, as advised by the company’s website, appear to be minimal. The singular entry states that the vaccine should not be administered to anyone with a “history of severe allergic reaction (eg anaphylaxis)”.
Warnings to immunisers provide additional guidance on the management of immediate, acute allergic reactions when administering the vaccine.
Its clinical trials have turned up some interesting information for aesthetic professionals, however. Specifically, with regard to the Moderna COVID vaccine effects on dermal filler patients.
Facial swelling in cheeks and lips
The list of adverse reactions to the Moderna vaccine is particularly relevant to aesthetics practitioners.
Two of the 155 individuals who took part in Moderna’s clinical trials experienced facial swelling. The swelling was located in their cheeks and lips. Both of these participants had dermal fillers and had experienced similar swelling previously after receiving a different vaccine.
Four cases of Bell’s Palsy were reported among participants, with three being vaccine recipients and one having received a placebo. There was no mention of any of these patients having dermal fillers.
It is unknown whether any other trial subjects who did not experience any adverse events also had dermal fillers.
What this means for treating filler patients
As we have already advised, it is wise for aesthetic practitioners to adjust their clinical consultation during this time. You will need to add more in-depth questions to establish a true picture of your patient’s mental health; now you will also need to know about their vaccination status.
In this case, you will need to speak to your patient ahead of time, when they are booking their appointment provides the ideal opportunity. However, it is also worth checking with them again during your consultation on the day of the appointment.
Ask if they are scheduled to have the vaccine, or if they have had the vaccine. If they are, or have, ask them when, which one and whether they have received one or two doses.
Should you discover they are about to receive either their first or second dose of the Moderna vaccine, you may wish to defer treatment. This is likely to be the best course of action just to be on the safe side, given very little is known about these vaccines yet.
At Harley Academy, our rule for these vaccines will be that patients can be treated with filler either four weeks before the first dose, or four weeks after the second dose.
Clearly explain the risks to your patient. Chances are, they will be happy to rebook for after their vaccination. If they do wish to proceed with getting fillers close to their vaccination date, it is up to you to make an ethical decision as to whether this is in their best interests – and stick to it! We know how persuasive patients can be but don’t let them sway you.
We have said it many times before but it bears repeating: let your patient’s welfare, rather than their wishes, guide your decision. Your reputation as a trustworthy, knowledgeable and ethical injector is at stake if you decide to treat someone who then has an adverse reaction to the vaccine as a result of their fillers.
As Moderna is expected to ship all its available doses by the end of 2020, this is unlikely to be an issue before January 2021. However, it is worth introducing these questions now as part of your new ‘best practice’ COVID routine, as the UK vaccine rollout is expected to extend into Spring 2021. There’s nothing like being prepared!